After years of displaying “No Rub” on its ReNu MultiPlus bottles, Bausch + Lomb has decided to remove the phrase and include a rub and rinse regimen in the directions of all its multipurpose contact lens solutions. “By choosing to proactively change our multi-purpose solution labeling to only include a rub regimen for cleaning and disinfecting lenses, we are providing patients with the insights we’ve gained from the 92% of eye care professionals who instruct their patients to rub their lenses,” says Mohinder Merchea, O.D., Ph.D., M.B.A., B+L’s director of Medical Affairs, North America Vision Care.

Taprenepag, an EP2 receptor agonist, demonstrated comparable IOP-lowering efficacy to that of the F2-alpha agonist latanoprost (Xalatan, Pfizer), according to a study reported at this year’s American Academy of Ophthalmology meeting in Chicago. The study also found that combination therapy of taprenepag and latanoprost lowered patients’ IOP more effectively than monotherapy with either agent. However, EP2 agonists can yield more adverse side effects, such as photophobia, iritis and reduced visual acuity.

Which is better, upper or lower? Either upper or lower punctal occlusion for the treatment of dry eye is equally effective, according to a study in the November issue of Investigative Ophthalmology and Visual Science. Following upper occlusion of one eye and lower occlusion of the fellow eye, 20 dry eye patients exhibited statistically similar improvements in fluorescein staining scores, TFBUT and lower tear meniscus height.